/Passle/5e8c58ad3dccd208784b45a3/MediaLibrary/Images/2024-10-15-19-53-27-360-670ec837dd71ccaa0996a993.png)
On March 26, 2026, the US Department of Justice Antitrust Division (DOJ) brought a civil action against New York-Presbyterian Hospital...
A Fresh Take
Insights on US legal developments
Last week brought a one‑two punch for Nexstar’s proposed $6.2 billion acquisition of Tegna. On March 18th, eight state attorneys...
Key Takeaways The FTC is intensifying scrutiny of practices that delay generic and biosimilar entry.Strategies that extend exclusivity...
On March 19, 2026, the U.S. Court of Appeals for the Fifth Circuit denied the Federal Trade Commission’s (FTC) emergency motion for a...
For years, websites and apps have faced a regulatory paradox: verifying a user’s age may be necessary to comply with the Children’s...
On February 20, 2026, the US Department of Justice Antitrust Division (DOJ) and the Ohio Attorney General (Ohio AG) brought a civil...
On February 12, 2026, the U.S. District Court for the Eastern District of Texas vacated the Federal Trade Commission’s (FTC) rule...
Edwards Lifesciences Corp. (Edwards) abandoned its $945 million acquisition of JenaValve Technology, Inc. (JenaValve) after the U.S....
Regulators are making it clear that 2026 will be a big year for scrutiny of algorithmic pricing models, the use of personal data and...
On January 14, 2026, the US Federal Trade Commission (FTC) announced its annual updates to the Hart-Scott-Rodino (HSR) Act reportability...
Life sciences is a high-stakes sector where antitrust enforcement is testing the boundaries of competition law. The focus differs sharply...
The generous $1 million award is expected to be the first of many as whistleblowers “frenzy” to report antitrust misconduct. On January...